Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses

被引:56
作者
Sitterlin, D
Bergametti, F
Tiollais, P
Tennant, BC
Transy, C
机构
[1] Inst Pasteur, Unite Recombinais & Express Genet, INSERM, U163, F-75724 Paris 15, France
[2] Cornell Univ, Coll Vet Med, Dept Clin Sci, Vet Med Ctr C2 005, Ithaca, NY 14853 USA
关键词
hepatitis B virus; X protein; UV-damaged DNA binding protein; virus-host interaction; therapeutic target;
D O I
10.1038/sj.onc.1203770
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A fully effective treatment of chronic human hepatitis B virus (I-IBV) infection is still missing and HBV remains the first etiological agent of liver cancer. Although the viral regulatory X protein is essential for infection, its mode of action remains obscure, due the lark of an in vitro infection system. In the accompanying study, we showed the functional importance of interaction between X and the host protein UVDDB-p127, in the transactivation and apoptotic properties of the viral protein, Here, we addressed the biological role of X-UVDDB interaction in the infectious process using a genetic approach in the woodchuck virus closely related to HBV. We show that (i) mutations in X, which markedly affect UVDDB-binding, also abolished productive infection in woodchucks, (ii) in the few cases where mutant viruses led to infection, compensatory mutations had occurred in the X gene of the viral progeny, which restored correct UVDDB-binding. We conclude that efficient viral replication in vivo requires proper X-UVDDB interaction. The interaction may thus provide a novel therapeutic target for the treatment of hepatitis B.
引用
收藏
页码:4427 / 4431
页数:5
相关论文
共 21 条
  • [1] BEASLEY RP, 1981, LANCET, V2, P1129
  • [2] The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines
    Bergametti, F
    Prigent, S
    Luber, B
    Benoit, A
    Tiollais, P
    Sarasin, A
    Transy, C
    [J]. ONCOGENE, 1999, 18 (18) : 2860 - 2871
  • [3] HEPATITIS-B VIRUS X-PROTEIN IS NOT CENTRAL TO THE VIRAL LIFE-CYCLE INVITRO
    BLUM, HE
    ZHANG, ZS
    GALUN, E
    VONWEIZSACKER, F
    GARNER, B
    LIANG, TJ
    WANDS, JR
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (02) : 1223 - 1227
  • [4] THE WOODCHUCK HEPATITIS VIRUS-X GENE IS IMPORTANT FOR ESTABLISHMENT OF VIRUS-INFECTION IN WOODCHUCKS
    CHEN, HS
    KANEKO, S
    GIRONES, R
    ANDERSON, RW
    HORNBUCKLE, WE
    TENNANT, BC
    COTE, PJ
    GERIN, JL
    PURCELL, RH
    MILLER, RH
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (03) : 1218 - 1226
  • [5] The hepatitis B virus X gene induces p53-mediated programmed cell death
    Chirillo, P
    Pagano, S
    Natoli, G
    Puri, PL
    Burgio, VL
    Balsano, C
    Levrero, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 8162 - 8167
  • [6] The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter
    Fourel, G
    Ringeisen, F
    Flajolet, M
    Tronche, F
    Pontoglio, M
    Tiollais, P
    Buendia, MA
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8571 - 8583
  • [7] NUCLEOTIDE-SEQUENCE OF THE HEPATITIS-B VIRUS GENOME (SUBTYPE AYW) CLONED IN ESCHERICHIA-COLI
    GALIBERT, F
    MANDART, E
    FITOUSSI, F
    TIOLLAIS, P
    CHARNAY, P
    [J]. NATURE, 1979, 281 (5733) : 646 - 650
  • [8] COMPLETE NUCLEOTIDE-SEQUENCE OF A MOLECULAR CLONE OF WOODCHUCK HEPATITIS-VIRUS THAT IS INFECTIOUS IN THE NATURAL HOST
    GIRONES, R
    COTE, PJ
    HORNBUCKLE, WE
    TENNANT, BC
    GERIN, JL
    PURCELL, RH
    MILLER, RH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) : 1846 - 1849
  • [9] The mechanism of action of cyclosporin A and FK506
    Ho, S
    Clipstone, N
    Timmermann, L
    Northrop, J
    Graef, I
    Fiorentino, D
    Nourse, J
    Crabtree, GR
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : S40 - S45
  • [10] Status of hepatitis B immunization programmes in 1998
    Kane, MA
    [J]. VACCINE, 1998, 16 : S104 - S108